Actively Recruiting

All Genders
NCT05954416

FARD (RaDiCo Cohort) (RaDiCo-FARD)

Led by Institut National de la Santé Et de la Recherche Médicale, France · Updated on 2026-02-12

900

Participants Needed

15

Research Sites

469 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational study is to conduct a prospective assessment of the individual Burden of 9 rare skin diseases to assess disability in the broadest sense of the term (psychological, social, economic and physical) for patients and/or families. Two types of indicators will be used to reach this objective : 1. an individual burden score calculated based on a burden questionnaire created specifically, approved and designed to understand the tendency to changes in care and lifestyles. The burden questionnaire should be used by patients and/or their family themselves in self-assessment. 2. a descriptive analysis of all resources (medical and non-medical) used by the family unit to manage the disease.

CONDITIONS

Official Title

FARD (RaDiCo Cohort) (RaDiCo-FARD)

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults or children with a confirmed diagnosis of one of the nine rare skin diseases: Inherited Epidermolysis Bullosa, Ichthyosis, Ectodermal Dysplasia, Incontinentia Pigmenti, Neurofibromatosis Type 1, Albinism, Pemphigus, Mucous Membrane Pemphigoid, or Palmoplantar Keratoderma
  • Prevalent or new cases followed at a reference or competence center within the FIMARAD healthcare network
  • Able to understand the survey (parents must understand for children)
  • Signed consent provided to participate in the RaDiCo-FARD cohort (parental consent for children)
Not Eligible

You will not qualify if you...

  • Patients who cannot maintain regular care follow-up with FIMARAD network sites
  • Unconfirmed diagnosis according to disease-specific criteria
  • Patients or parents unable to understand the survey
  • Patients or parents who have not signed consent to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 15 locations

1

Hôpital Avicenne

Bobigny, France

Not Yet Recruiting

2

Hôpital des Enfants - Groupe Hospitalier Pellegrin

Bordeaux, France

Not Yet Recruiting

3

Hôpital des Enfants - Groupe Hospitalier Pellegrin

Bordeaux, France

Not Yet Recruiting

4

Hôpital Henri-Mondor

Créteil, France

Not Yet Recruiting

5

Hôpital François Mitterrand

Dijon, France

Not Yet Recruiting

6

Hôpital Dupuytren

Limoges, France

Not Yet Recruiting

7

Hôpital de la Timone

Marseille, France

Not Yet Recruiting

8

Hôpital Saint-Eloi

Montpellier, France

Not Yet Recruiting

9

Hôpital l'Archet

Nice, France

Actively Recruiting

10

Hôpital Necker-Enfants Malades

Paris, France

Actively Recruiting

11

Hôpital Saint-Louis

Paris, France

Actively Recruiting

12

Hôpital Robert-Debré

Reims, France

Not Yet Recruiting

13

Hôpital Charles Nicolle

Rouen, France

Actively Recruiting

14

Hôpital Larrey

Toulouse, France

Actively Recruiting

15

Hôpital Trousseau

Tours, France

Actively Recruiting

Loading map...

Research Team

C

Christine BODEMER

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here